Revlon Clocks 1.8% Sales Decline In Q4
Revlon Inc (NYSE:REV) reported a fourth-quarter FY21 sales decline of 1.8% year-on-year, to $615.2 million, missing the consensus of $645.60 million.…
Revlon: Q4 Earnings Insights
Revlon (NYSE:REV) reported its Q4 earnings results on Thursday, March 3, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
Revlon Q4 EPS $0.34 May Not Compare To $0.06 Estimate, Sales $615.20M Miss $645.60M Estimate
Revlon (NYSE:REV) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.06 by 466.67 percent. This is a 44.26 percent decrease over earnings of $0.61 per share from the same
Earnings Scheduled For March 3, 2022
Companies Reporting Before The Bell
• Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million.
26 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Puxin Limited (NYSE: NEW) jumped 100.5% to $0.6016 after reporting results for the second quarter.
Revlon’s Return On Capital Employed Insights
According to Benzinga Pro, during Q3, Revlon (NYSE:REV) earned $34.20 million, a 169.29% increase from the preceding quarter. Revlon also posted a total of $521.10 million in sales, a 4.76% increase since Q2.
Revlon Shares Spike On Narrower-Than-Expected Loss In Q3; Notes Margin Expansion
Revlon Inc (NYSE:REV) reported third-quarter FY21 sales growth of 9.2% year-on-year, to $521.1 million, missing the analyst consensus of $549.80 million.…
64 Stocks Moving In Friday’s Mid-Day Session
Gainers
Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the estimated price range of $4-$6, for raising gross proceeds of $10 million.